Japanese Urological Association guidelines on prostate‐specific antigen‐based screening for prostate cancer and the ongoing cluster cohort study in Japan

Cancer Statistics, 2008

2008 • 10,165 citations

American Cancer Society Guidelines for the Early Detection of Cancer

2002 • 1,652 citations

American Cancer Society Guidelines for the Early Detection of Cancer, 2006

2006 • 641 citations

Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and Connecticut

2002 • 223 citations

Geographic Patterns of Prostate Cancer Mortality and Variations in Access to Medical Care in the United States

2005 • 147 citations

Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized Controlled Trial

2006 • 136 citations

Tyrol Prostate Cancer Demonstration Project: early detection, treatment, outcome, incidence and mortality

2008 • 126 citations

Complication rates of ultrasound‐guided prostate biopsy: A nation‐wide survey in Japan

2008 • 89 citations

Trends in prostate cancer incidence and mortality: an analysis of mortality change by screening intensity.

2003 • 81 citations

Trends in prostate cancer incidence, mortality and survival in England and Wales 1971–1998

2000 • 74 citations

PSA screening and prostate cancer mortality.

2002 • 73 citations

Prostate-specific antigen (PSA) best practice policy. American Urological Association (AUA).

2000 • 65 citations

Rising incidence of prostate cancer in Scotland: increased risk or increased detection?

2000 • 63 citations

Trends in incidence and mortality rates for prostate cancer before and after prostate-specific antigen introduction. A registry-based study in Southeastern Netherlands, 1971–1995

1998 • 57 citations

Usefulness of age-specific reference range of prostate-specific antigen for japanese men older than 60 years in mass screening for prostate cancer

2000 • 52 citations

Prostate cancer in Western Australia: trends in incidence and mortality from 1985 to 1996

1998 • 50 citations

Possibility of re‐screening intervals of more than one year in men with PSA levels of 4.0 ng/ml or less

2003 • 46 citations

Effectiveness of mass screening for the prognosis of prostate cancer patients in Japanese communities

2002 • 39 citations

Prostate cancer in Saskatchewan Canada, before and during the PSA era.

2000 • 29 citations

Cumulative probability of PSA increase above 4.0 NG/ML in population‐based screening for prostate cancer

2004 • 27 citations

Ten year trend in prostate cancer screening with high prostate‐specific antigen exposure rate in Japan

2008 • 27 citations

Epidemiology of prostate cancer in the Umbria region of Italy: evidence of opportunistic screening effects

2003 • 16 citations

The Risk of Rapid Prostate Specific Antigen Increase in Men With Baseline Prostate Specific Antigen 2.0 ng/ml or Less

2004 • 12 citations

Lead Time of Prostate Cancer Detected in Population Based Screening for Prostate Cancer in Japan

2007 • 9 citations

1756: The Tyrol Prostate Cancer Demonstration Project (1988-2006): Early Detection, Treatment, Outcome, Incidence and Mortality

2007 • 1 citations